{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T05:34:14Z","timestamp":1775367254697,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32171381"],"award-info":[{"award-number":["32171381"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20240149"],"award-info":[{"award-number":["BK20240149"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.colsurfb.2025.114585","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T19:29:59Z","timestamp":1739993399000},"page":"114585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["GRP94 mediates blood-brain barrier permeation and substantia nigra-specific drug distribution in Parkinson\u2019s disease"],"prefix":"10.1016","volume":"250","author":[{"given":"Ziyan","family":"Lv","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuteng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiyong","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.colsurfb.2025.114585_bib1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","article-title":"The epidemiology of Parkinson's disease","volume":"403","author":"Ben-Shlomo","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.colsurfb.2025.114585_bib2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","article-title":"The pathogenesis of Parkinson's disease","volume":"403","author":"Morris","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.colsurfb.2025.114585_bib3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12974-022-02496-w","article-title":"The role of Toll-like receptors and neuroinflammation in Parkinson's disease","volume":"19","author":"Heidari","year":"2022","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.colsurfb.2025.114585_bib4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tins.2022.11.007","article-title":"\u00e9, \u03b1-Synuclein in synaptic function and dysfunction","volume":"46","author":"Sharma","year":"2023","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.colsurfb.2025.114585_bib5","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/acn3.51776","article-title":"LRRK2 and Parkinson's disease: from genetics to targeted therapy","volume":"10","author":"Sosero","year":"2023","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.colsurfb.2025.114585_bib6","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.tins.2018.11.001","article-title":"Synaptic, mitochondrial, and lysosomal dysfunction in Parkinson's disease","volume":"42","author":"Nguyen","year":"2019","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.colsurfb.2025.114585_bib7","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0140-6736(23)01429-0","article-title":"Medical, surgical, and physical treatments for Parkinson's disease","volume":"403","author":"Foltynie","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.colsurfb.2025.114585_bib8","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1016\/j.apsb.2020.11.023","article-title":"Evolution of blood-brain barrier in brain diseases and related systemic nanoscale brain-targeting drug delivery strategies","volume":"11","author":"Han","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.colsurfb.2025.114585_bib9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood-brain barrier: structure, regulation, and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.colsurfb.2025.114585_bib10","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41573-021-00139-y","article-title":"Strategies for delivering therapeutics across the blood-brain barrier","volume":"20","author":"Terstappen","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.colsurfb.2025.114585_bib11","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.3390\/pharmaceutics13122024","article-title":"Modulation of the blood-brain barrier for drug delivery to brain","volume":"13","author":"Han","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2025.114585_bib12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41568-019-0205-x","article-title":"The blood-brain barrier and blood-tumour barrier in brain tumours and metastases","volume":"20","author":"Arvanitis","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.colsurfb.2025.114585_bib13","article-title":"Brain-targeted liposomes loaded with monoclonal antibodies reduce alpha-synuclein aggregation and improve behavioral symptoms in Parkinson's disease","volume":"35","author":"Sela","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.colsurfb.2025.114585_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202470257","article-title":"Nanotherapeutic approaches of interleukin-3 to clear the alpha-synuclein pathology in mouse models of Parkinson's disease","author":"Zhang","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.colsurfb.2025.114585_bib15","doi-asserted-by":"crossref","first-page":"7837","DOI":"10.1021\/acsnano.3c05864","article-title":"Ultrasound-assisted CRISPRi-exosome for epigenetic modification of alpha-synuclein gene in a mouse model of Parkinson's disease","volume":"18","author":"Kong","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.colsurfb.2025.114585_bib16","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.2147\/IJN.S468942","article-title":"Key lipoprotein receptor targeted echinacoside-liposomes effective against Parkinson's disease in mice model","volume":"19","author":"Ou","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.colsurfb.2025.114585_bib17","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41586-020-2156-5","article-title":"LRP1 is a master regulator of tau uptake and spread","volume":"580","author":"Rauch","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.colsurfb.2025.114585_bib18","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1523\/JNEUROSCI.5367-11.2012","article-title":"Endoplasmic reticulum stress is important for the manifestations of alpha-synucleinopathy in vivo","volume":"32","author":"Colla","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.colsurfb.2025.114585_bib19","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1093\/hmg\/ddr502","article-title":"The homocysteine-inducible endoplasmic reticulum (ER) stress protein Herp counteracts mutant alpha-synuclein-induced ER stress via the homeostatic regulation of ER-resident calcium release channel proteins","volume":"21","author":"Belal","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.colsurfb.2025.114585_bib20","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2174\/1566524016666160523143937","article-title":"The role of the PERK\/eIF2alpha\/ATF4\/CHOP signaling pathway in tumor progression during endoplasmic reticulum stress","volume":"16","author":"Rozpedek","year":"2016","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.colsurfb.2025.114585_bib21","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3390\/cells10030670","article-title":"Cell surface GRP94 as a novel emerging therapeutic target for monoclonal antibody cancer therapy","volume":"10","author":"Kim","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.colsurfb.2025.114585_bib22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1462-5822.2009.01379.x","article-title":"Nitric oxide\/cGMP signalling induces Escherichia coli K1 receptor expression and modulates the permeability in human brain endothelial cell monolayers during invasion","volume":"12","author":"Mittal","year":"2010","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.colsurfb.2025.114585_bib23","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1111\/j.1462-5822.2008.01214.x","article-title":"Escherichia coli interaction with human brain microvascular endothelial cells induces signal transducer and activator of transcription 3 association with the C-terminal domain of Ec-gp96, the outer membrane protein A receptor for invasion","volume":"10","author":"Maruvada","year":"2008","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.colsurfb.2025.114585_bib24","doi-asserted-by":"crossref","first-page":"2105854","DOI":"10.1002\/advs.202105854","article-title":"Biomimetic lipopolysaccharide-free bacterial outer membrane-functionalized nanoparticles for brain-targeted drug delivery","volume":"9","author":"Chen","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.colsurfb.2025.114585_bib25","doi-asserted-by":"crossref","first-page":"2300403","DOI":"10.1002\/smll.202300403","article-title":"DH5alpha outer membrane-coated biomimetic nanocapsules deliver drugs to brain metastases but not normal brain cells via targeting GRP94","volume":"19","author":"Zhou","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.colsurfb.2025.114585_bib26","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jconrel.2024.09.003","article-title":"Brain-tumor-seeking and serpin-inhibiting outer membrane vesicles restore plasmin-mediated attacks against brain metastases","volume":"375","author":"Zhou","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2025.114585_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118461","article-title":"TRPV4 contributes to ER stress: relation to apoptosis in the MPP(+)-induced cell model of Parkinson's disease","volume":"261","author":"Liu","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.colsurfb.2025.114585_bib28","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1172\/JCI61332","article-title":"Neurotoxin-induced ER stress in mouse dopaminergic neurons involves downregulation of TRPC1 and inhibition of AKT\/mTOR signaling","volume":"122","author":"Selvaraj","year":"2012","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.colsurfb.2025.114585_bib29","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1128\/iai.64.1.146-153.1996","article-title":"Outer membrane protein A of Escherichia coli contributes to invasion of brain microvascular endothelial cells","volume":"64","author":"Prasadarao","year":"1996","journal-title":"Infect. Immun."},{"key":"10.1016\/j.colsurfb.2025.114585_bib30","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1021\/acs.molpharmaceut.1c00224","article-title":"Prodrug delivery using dual-targeting nanoparticles to treat breast cancer brain metastases","volume":"18","author":"Ju","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.colsurfb.2025.114585_bib31","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/s41467-020-14788-x","article-title":"Pyridoxine induces glutathione synthesis via PKM2-mediated Nrf2 transactivation and confers neuroprotection","volume":"11","author":"Wei","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.colsurfb.2025.114585_bib32","doi-asserted-by":"crossref","first-page":"1900259","DOI":"10.1002\/adfm.201900259","article-title":"Nanoparticles surmounting blood-brain tumor barrier through both transcellular and paracellular pathways to target brain metastases","volume":"29","author":"Miao","year":"2019","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.colsurfb.2025.114585_bib33","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2019.04.031","article-title":"LRP1-upregulated nanoparticles for efficiently conquering the blood-brain barrier and targetedly suppressing multifocal and infiltrative brain metastases","volume":"303","author":"Guo","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2025.114585_bib34","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jconrel.2020.10.023","article-title":"PSMA-targeted nanoparticles for specific penetration of blood-brain tumor barrier and combined therapy of brain metastases","volume":"329","author":"Ni","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2025.114585_bib35","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jconrel.2024.03.047","article-title":"Nanomodulators targeting endothelial WNT and pericytes to reversibly open the blood-tumor barrier for boosted brain tumor therapy","volume":"369","author":"Mu","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2025.114585_bib36","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.apsb.2020.10.015","article-title":"Escape from abluminal LRP1-mediated clearance for boosted nanoparticle brain delivery and brain metastasis treatment","volume":"11","author":"Khan","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.colsurfb.2025.114585_bib37","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1016\/j.apsb.2024.03.024","article-title":"Suppressing Wnt signaling of the blood\u2013tumor barrier to intensify drug delivery and inhibit lipogenesis of brain metastases","volume":"14","author":"Tong","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.colsurfb.2025.114585_bib38","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12974-022-02382-5","article-title":"TRPV4 contributes to ER stress and inflammation: implications for Parkinson's disease","volume":"19","author":"Liu","year":"2022","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.colsurfb.2025.114585_bib39","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002230","article-title":"Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target","volume":"3","author":"Yu","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.colsurfb.2025.114585_bib40","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0163-7258(01)00161-9","article-title":"Neuronal nicotinic acetylcholine receptor subunit knockout mice: physiological and behavioral phenotypes and possible clinical implications","volume":"92","author":"Picciotto","year":"2001","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.colsurfb.2025.114585_bib41","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/(SICI)1096-9861(19971027)387:3<385::AID-CNE5>3.0.CO;2-X","article-title":"Comparison of the regional expression of nicotinic acetylcholine receptor alpha7 mRNA and [125I]-alpha-bungarotoxin binding in human postmortem brain","volume":"387","author":"Breese","year":"1997","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.colsurfb.2025.114585_bib42","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/s12974-021-02341-6","article-title":"Mechanisms underlying antidepressant effect of transcutaneous auricular vagus nerve stimulation on CUMS model rats based on hippocampal alpha7nAchR\/NF-kappaB signal pathway","volume":"18","author":"Wang","year":"2021","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.colsurfb.2025.114585_bib43","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.tins.2021.11.006","article-title":"\u03b17 nicotinic acetylcholine receptors in the hippocampal circuit: taming complexity","volume":"45","author":"Letsinger","year":"2022","journal-title":"Trends Neurosci."}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092777652500092X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092777652500092X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T08:12:39Z","timestamp":1762330359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092777652500092X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":43,"alternative-id":["S092777652500092X"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2025.114585","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GRP94 mediates blood-brain barrier permeation and substantia nigra-specific drug distribution in Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2025.114585","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114585"}}